Transferência deferida
#25.1
02/04/2025
RPI 2822
Application data
Number
112023011284Type
Filing
Publication
PCT
US2021062565 The application was filed at the INPI on 12/09/2021. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 02/04/2025. We update with every new RPI gazette, published weekly.
Applicants
PHARMA CINQ, LLC
US
W. C. (pessoa física)
US
Inventors
D. S. (pessoa física)
US
R. B. (pessoa física)
US
R. G. (pessoa física)
US
IPC Classification
Priority claims
US
63/122,999 · 12/09/2020
Abstract
COMPOSTO DE IMIDAZOQUINOLINA COM ATIVIDADE ANTI-INFLAMATÓRIA, ANTIFÚNGICA, ANTIPARASÍTICA E ANTINEOPLÁSICA.A presente invenção refere-se a um composto de imidazoquinolina com atividade contra inflamação, fungos, micro-organismos parasitas unicelulares e câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#25.1
02/04/2025
RPI 2822
#1.3
02/06/2024
RPI 2770
#1.1
06/20/2023
RPI 2737
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.